OpenURL Connection Search

Select item for more details and to access through your institution.

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Published in:
2024
By:
- Altorki, Nasser K.;
- Walsh, Zachary H.;
- Melms, Johannes C.;
- Port, Jeffery L.;
- Lee, Benjamin E.;
- Nasar, Abu;
- Spinelli, Cathy;
- Caprio, Lindsay;
- Rogava, Meri;
- Ho, Patricia;
- Christos, Paul J.;
- Saxena, Ashish;
- Elemento, Olivier;
- Bhinder, Bhavneet;
- Ager, Casey;
- Amin, Amit Dipak;
- Sanfilippo, Nicholas J.;
- Mittal, Vivek;
- Borczuk, Alain C.;
- Formenti, Silvia C.
Publication type:
Correction Notice
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44195-x
By:
- Altorki, Nasser K.;
- Walsh, Zachary H.;
- Melms, Johannes C.;
- Port, Jeffery L.;
- Lee, Benjamin E.;
- Nasar, Abu;
- Spinelli, Cathy;
- Caprio, Lindsay;
- Rogava, Meri;
- Ho, Patricia;
- Christos, Paul J.;
- Saxena, Ashish;
- Elemento, Olivier;
- Bhinder, Bhavneet;
- Ager, Casey;
- Amin, Amit Dipak;
- Sanfilippo, Nicholas J.;
- Mittal, Vivek;
- Borczuk, Alain C.;
- Formenti, Silvia C.
Publication type:
Article
National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches.
Published in:
European Journal of Cardio-Thoracic Surgery, 2019, v. 56, n. 4, p. 762, doi. 10.1093/ejcts/ezz111
By:
- Kamel, Mohamed K;
- Villena-Vargas, Jonathan;
- Rahouma, Mohamed;
- Lee, Benjamin;
- Harrison, Sebron;
- Stiles, Brendon M;
- Abdelrahman, Abdelrahman M;
- Altorki, Nasser K;
- Port, Jeffery L
Publication type:
Article

Found: 3

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.

National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches.